Ghasem Saki

Ghasem Saki


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2018 in Medicina
Verified
Journal Article
Open access
PDF file
MMMaryam Mombeini
Maryam Mombeini
GSGhasem Saki
Ghasem Saki
LKLayasadat Khorsandi
Layasadat Khorsandi
NBNeda Bavarsad
Neda Bavarsad
Background and objective: Previous studies have demonstrated the anti-cancer effects of silymarin (SLM). However, the low bioavailability of SLM has restricted its use. This study investigated the toxic effect of nanostructured SLM encapsulated in micelles (Nano-SLM) on the growth of the HT-29 human colon cancer cell line. Materials and methods: HT-29 cells were treated with 25 μM/mL of SLM or Nano-SLM for 48 h. MTT and colony formation assays were used to assess the cytotoxicity and proliferation of HT-29 cells, respectively. The cells were stained with annexin V/PI for assessment of apoptosis. Results: MTT assays revealed that Nano-SLM treatment was able to exert a more pronounced toxic effect on the HT-29 cells as compared to free SLM treatment (p < 0.01). In the Nano-SLM-treated cells, colony numbers were significantly reduced in comparison to the free SLM-treated cells (p < 0.01). Apoptotic and necrotic indexes of Nano-SLM-treated HT-29 cells were also significantly increased in comparison to those of the free SLM-treated cells (p < 0.01). The viability, proliferation and apoptosis of healthy cells (NIH-3T3 cells) were not changed in response to Nano-SLM or SLM. Conclusions: Our results indicate that Nano-SLM enhances the anti-cancer effects of SLM against human colon cancer cells.

5 February 2014 in Iranian Red Crescent Medical Journal
Verified
Journal Article
Open access
PDF file
MMMehri Mirhoseini
Mehri Mirhoseini
GSGhasem Saki
Ghasem Saki
MHMasoud Hemadi
Masoud Hemadi
AKAli Khodadadi
Ali Khodadadi
JAJavad Mohammadi Asl
Javad Mohammadi Asl
Background: Advancement in the treatment of various types of cancer has led to greater patient survival. These treatments essentially have toxic effects on different kinds of cells, such as germ cells. Infertility as one of the side effects of cancer treatment has changed the quality of life of young cancer survivors dramatically. Melatonin is an antioxidant with receptors in the reproductive systems. Objectives: We supposed that melatonin, as an antioxidant, may protect testis against the toxic effects of the drugs. Materials and Methods: In this experimental study, three groups with seven mice each, were allocated. The control group received normal saline for two months, and the busulfan group received a single dose of 40 mg/kg busulfan intra-peritoneally, and the melatonin group received 20 mg/kg melatonin daily for two months, 45 days after a single dose of busulfan. Next, after decapitation and removal of the testis, tissues were fixed in Bouin's solution and stained by H&E and TUNEL. The sections were evaluated, assessing morphology and spermatogenesis. Results: In this research, a significant reduction in Johnson’s criteria in the busulfan group (Mean rank = 15.50) was found versus the control group (Mean rank = 45.50), P < 0.001 and in the melatonin group (Mean rank = 45.50) compared to the busulfan group (Mean rank = 15.50), P < 0.001. There was a significant difference between the melatonin and control groups, P < 0.05. In addition, a significant decrease in seminiferous tubule diameter was observed in the busulfan group (763.2 ± 104.41) versus the control group (855.4 ± 52.35), P < 0.01 and melatonin group (834.2 ± 87.26), P < 0.05. Testicular epithelium height was significantly decreased in the busulfan group (Mean rank = 14.60) compared to the control group (Mean rank = 26.40), P < 0.01 and in the busulfan group (Mean rank = 14.95) in comparison with the melatonin group (Mean rank = 26.05), P < 0.01. Also melatonin group (Mean rank = 25.42) showed a significant reduction in epithelium height compared to the control group (Mean rank = 35.58), P < 0.05. Spermatogenesis was impaired in the busulfan group. Although melatonin reduced the rate of apoptosis in the busulfan group, yet it could not remove all apoptotic cells. Conclusions: This study indicated that melatonin ameliorates the cytotoxic effects of busulfan on germ cells. Keywords: Melatonin; Spermatogenesis; Busulfan; Mice; Testis

1 January 2012 in Journal of Human Reproductive Sciences
Verified
Journal Article
Open access
PDF file
MJMaryam Jalali
Maryam Jalali
GSGhasem Saki
Ghasem Saki
ASAlireza Sarkaki
Alireza Sarkaki
KKKhodabakhsh Karami
Khodabakhsh Karami
SNSima Nasri
Sima Nasri
AIMS: It was decided to investigate the effect of noise pollution on the body weight, genital organ weights, and also on sperm parameters. SETTING AND DESIGN: It is a prospective study designed in vitro. MATERIALS AND METHODS: A total 20 adult male wistar rats were used in this study. All rats were divided into 2 equal groups (n = 10): (1) control group and (2) experimental group. Animals of the experimental group were exposed to noise for 50 days with an intensity of 90-120 db and frequency of 300 - 350 Hz for 12 hours daily. After 50 days, at first, body weights of all animals were recorded, and then they were killed. The right epididymides were removed and also, sperm concentration and motility were determined. Each organ was weighed separately on an electronic balance. STATISTICAL ANALYSIS USED: Data are reported as mean ± SD and percentage. The statistical significance of difference between the control and experimental groups was determined by the unpaired t-test. RESULTS: The weights of the testes, epididymes, seminal vesicle, ventral prostate were found to be significantly decreased in rats exposed to noise pollution when compared with the weights of the same organs obtained from control group (P < 0.05). There was a statistical difference of P < 0.05 between the 2 groups in terms of sperm concentration. CONCLUSIONS: It is concluded that noise pollution has the bad effects on sperm concentration and motility; therefore, it is supposed that homes and places of working must be build far away of noisy of factories and other places with noise.

1 March 2009 in Pakistan Journal of Biological Sciences
Verified
Journal Article
Closed access
MDM. Davoodi
M. Davoodi
NSNader Saki
Nader Saki
GSGhasem Saki
Ghasem Saki
FRFakher Rahim
Fakher Rahim
Anatomical Variations of Neurovascular Structures Adjacent Sphenoid Sinus by using CT Scan

23 July 2013 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
MGMohammad Reza Gholami
Mohammad Reza Gholami
MHMasoud Hemadi
Masoud Hemadi
GSGhasem Saki
Ghasem Saki
AZAbolfazl Zendedel
Abolfazl Zendedel
AKAli Khodadadi
Ali Khodadadi
JMJavad Mohammadi-Asl
Javad Mohammadi-Asl

13 May 2019 in ACS Omega
Verified
Journal Article
Open access
SMSomaye Mirzaaghaei
Somaye Mirzaaghaei
AFAli M. Foroughmand
Ali M. Foroughmand
GSGhasem Saki
Ghasem Saki
MSMohammad Shafei
Mohammad Shafei
Despite promising benefits, anti-angiogenic strategies have revealed several drawbacks, which necessitate development of novel approaches in cancer therapy strategies including non-small-cell lung cancer, as one of the leading causes of cancer death, all over the world. Combination of flavonoids could be a safe and effective option to synergize their impact on mechanisms controlling tumor angiogenesis. In this study, we have investigated the plausible synergism of epigallocatechin-3-gallate (EGCG) and silibinin on endothelial cells, for the first time. Cell viability and migration were evaluated by survival and wound healing assays, respectively. Then, we assessed the expression of VEGF, VEGFR2, and miR-17–92 cluster using real-time polymerase chain reaction in endothelial–tumor cell and endothelial–fibroblast coculture models. EGCG ± silibinin suppressed endothelial and lung tumor cell migration in lower than 50% toxic doses. VEGF, VEGFR2, and pro-angiogenic members of the miR-17–92 cluster were downregulated upon treatments. Specifically, the combination treatment upregulated an anti-angiogenic member of the cluster, miR-19b. Our data provides evidence to utilize the EGCG and silibinin combination as a novel approach to target tumor angiogenesis in the future.